Fingerprint
Dive into the research topics of 'Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study: J Natl Compr Canc Netw'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study: J Natl Compr Canc Netw
James Perkins, Patrick Boland, Steven J. Cohen, Anthony J. Olszanski, Yan Zhou, Paul Engstrom, Igor Astsaturov
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations